Where does Duo Oncology's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Duo Oncology's 3 recorded funding rounds.

Premier Alternatives

Duo Oncology

Pittsburgh, PA · Founded 2020 · Privately Held (backing)

Developer of a clinical-stage biotechnology platform designed to replace traditional chemotherapy with more precise and tolerable cancer treatments. Duo Oncology is based in Pittsburgh, PA and was founded in 2020. It was valued at $25 million at its seed round in Jun 2025, the last priced event on record. It has raised $13.1 million across 3 recorded rounds; the latest was a $1.4 million seed round in Jun 2025.

PMV mark · valuation

$25.0M

Oct 2026

Priced at

its seed round

Jun 2025

Total raised

$13.1M

Last round

Seed Round

Jun 2025

Cap table — not yet on record

Duo Oncology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Duo Oncology with a free account

·Watch Duo Oncology: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Duo Oncology

Where does Duo Oncology's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Duo Oncology's 3 recorded funding rounds.